Today, our main supplier, Jiangxi Dadi Pharmaceutical Co., Ltd., started the site selection and construction of a production base project in Qiantang District, Hangzhou. The total investment of the project is about 2 billion yuan, which will be implemented in two phases. The total investment of the first phase is 1 billion yuan, and the land is about 56 acres. Build an annual production line with an annual output of 1 billion doses to produce enrofloxacin tablets, ceftiofur for injection, sallafloxacin hydrochloride solution and other products, with an output value of about 600 million yuan.
